

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.48485134 |
| 2 | urate metabolic process (GO:0046415) | 8.64637476 |
| 3 | drug transmembrane transport (GO:0006855) | 8.22113025 |
| 4 | drug transport (GO:0015893) | 7.68719331 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.59272964 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.40846848 |
| 7 | intestinal absorption (GO:0050892) | 6.78052284 |
| 8 | phosphate ion transport (GO:0006817) | 6.72860086 |
| 9 | modified amino acid transport (GO:0072337) | 6.60762387 |
| 10 | organic cation transport (GO:0015695) | 6.49125622 |
| 11 | lysine metabolic process (GO:0006553) | 6.41664357 |
| 12 | lysine catabolic process (GO:0006554) | 6.41664357 |
| 13 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.20257345 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 6.12125876 |
| 15 | drug catabolic process (GO:0042737) | 6.03864574 |
| 16 | phosphate ion transmembrane transport (GO:0035435) | 5.93902648 |
| 17 | cysteine metabolic process (GO:0006534) | 5.84756556 |
| 18 | fructose metabolic process (GO:0006000) | 5.75499987 |
| 19 | exogenous drug catabolic process (GO:0042738) | 5.65749645 |
| 20 | * regulation of guanylate cyclase activity (GO:0031282) | 5.56761037 |
| 21 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.56761037 |
| 22 | NADH metabolic process (GO:0006734) | 5.47029850 |
| 23 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.32105773 |
| 24 | quaternary ammonium group transport (GO:0015697) | 5.30040967 |
| 25 | endocrine process (GO:0050886) | 5.23431226 |
| 26 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.23431226 |
| 27 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.23431226 |
| 28 | lipoprotein transport (GO:0042953) | 5.08996592 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 5.08479886 |
| 30 | glutathione biosynthetic process (GO:0006750) | 5.01159743 |
| 31 | vitamin transport (GO:0051180) | 4.99074170 |
| 32 | excretion (GO:0007588) | 4.98051388 |
| 33 | glyoxylate metabolic process (GO:0046487) | 4.89748493 |
| 34 | renal system process involved in regulation of blood volume (GO:0001977) | 4.89271994 |
| 35 | diacylglycerol metabolic process (GO:0046339) | 4.87856661 |
| 36 | folic acid metabolic process (GO:0046655) | 4.87691391 |
| 37 | renal absorption (GO:0070293) | 4.84609731 |
| 38 | tricarboxylic acid metabolic process (GO:0072350) | 4.84131073 |
| 39 | response to mercury ion (GO:0046689) | 4.80796566 |
| 40 | folic acid transport (GO:0015884) | 4.80773246 |
| 41 | hormone catabolic process (GO:0042447) | 4.80750043 |
| 42 | regulation of systemic arterial blood pressure (GO:0003073) | 4.74845096 |
| 43 | regulation of cellular extravasation (GO:0002691) | 4.73650878 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.71482125 |
| 45 | vitamin D metabolic process (GO:0042359) | 4.62400245 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 4.60763250 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.60305852 |
| 48 | branched-chain amino acid metabolic process (GO:0009081) | 4.59679998 |
| 49 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.59392625 |
| 50 | oligosaccharide catabolic process (GO:0009313) | 4.47892862 |
| 51 | vitamin transmembrane transport (GO:0035461) | 4.46983450 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 4.40102265 |
| 53 | ketone body metabolic process (GO:1902224) | 4.37327362 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.35792763 |
| 55 | regulation of bile acid biosynthetic process (GO:0070857) | 4.35618815 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 4.30405311 |
| 57 | sulfur compound transport (GO:0072348) | 4.29429958 |
| 58 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.24268432 |
| 59 | aspartate family amino acid catabolic process (GO:0009068) | 4.23047948 |
| 60 | cellular glucuronidation (GO:0052695) | 4.22280773 |
| 61 | regulation of vitamin metabolic process (GO:0030656) | 4.21680819 |
| 62 | trivalent inorganic anion homeostasis (GO:0072506) | 4.20014427 |
| 63 | phosphate ion homeostasis (GO:0055062) | 4.20014427 |
| 64 | positive regulation of pseudopodium assembly (GO:0031274) | 4.17623589 |
| 65 | branched-chain amino acid catabolic process (GO:0009083) | 4.16658082 |
| 66 | glucuronate metabolic process (GO:0019585) | 4.16081268 |
| 67 | uronic acid metabolic process (GO:0006063) | 4.16081268 |
| 68 | carnitine transport (GO:0015879) | 4.05922045 |
| 69 | amino-acid betaine transport (GO:0015838) | 4.05922045 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 3.99432361 |
| 71 | urea cycle (GO:0000050) | 3.95841676 |
| 72 | toxin transport (GO:1901998) | 3.91659188 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.89329397 |
| 74 | antibacterial humoral response (GO:0019731) | 3.87575625 |
| 75 | peptide biosynthetic process (GO:0043043) | 3.87516389 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 3.86872362 |
| 77 | virion attachment to host cell (GO:0019062) | 3.86872362 |
| 78 | peptide hormone processing (GO:0016486) | 3.85459125 |
| 79 | antimicrobial humoral response (GO:0019730) | 3.83388074 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 3.83115770 |
| 81 | alditol metabolic process (GO:0019400) | 3.82922497 |
| 82 | biotin metabolic process (GO:0006768) | 3.80591591 |
| 83 | valine metabolic process (GO:0006573) | 3.80417666 |
| 84 | urea metabolic process (GO:0019627) | 3.78387685 |
| 85 | positive regulation of respiratory burst (GO:0060267) | 3.77796694 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.77296310 |
| 87 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.75198467 |
| 88 | regulation of pseudopodium assembly (GO:0031272) | 3.72747421 |
| 89 | sulfur amino acid catabolic process (GO:0000098) | 3.72252363 |
| 90 | peptide catabolic process (GO:0043171) | 3.69977714 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 3.69541306 |
| 92 | fatty acid beta-oxidation (GO:0006635) | 3.67579112 |
| 93 | glycoside metabolic process (GO:0016137) | 3.67342703 |
| 94 | actin filament depolymerization (GO:0030042) | 3.64661659 |
| 95 | tryptophan catabolic process (GO:0006569) | 3.63530431 |
| 96 | indole-containing compound catabolic process (GO:0042436) | 3.63530431 |
| 97 | indolalkylamine catabolic process (GO:0046218) | 3.63530431 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.61717866 |
| 99 | alkaloid metabolic process (GO:0009820) | 3.60261050 |
| 100 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.59691551 |
| 101 | proline metabolic process (GO:0006560) | 3.59568176 |
| 102 | glutathione derivative metabolic process (GO:1901685) | 3.59205493 |
| 103 | glutathione derivative biosynthetic process (GO:1901687) | 3.59205493 |
| 104 | glycosphingolipid catabolic process (GO:0046479) | 3.58185643 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.58175498 |
| 106 | digestion (GO:0007586) | 3.56212509 |
| 107 | glycolipid catabolic process (GO:0019377) | 3.56079792 |
| 108 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.53359909 |
| 109 | pantothenate metabolic process (GO:0015939) | 3.51900064 |
| 110 | sulfur amino acid metabolic process (GO:0000096) | 3.48605696 |
| 111 | nitrogen cycle metabolic process (GO:0071941) | 3.47998348 |
| 112 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.47358747 |
| 113 | glutathione metabolic process (GO:0006749) | 3.46858963 |
| 114 | digestive system process (GO:0022600) | 3.46629243 |
| 115 | protein-lipid complex assembly (GO:0065005) | 3.46382392 |
| 116 | metanephric nephron tubule development (GO:0072234) | 3.45633896 |
| 117 | metanephric tubule development (GO:0072170) | 3.45633896 |
| 118 | carnitine metabolic process (GO:0009437) | 3.44213497 |
| 119 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41521190 |
| 120 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.40475481 |
| 121 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.40474430 |
| 122 | fatty acid oxidation (GO:0019395) | 3.39549210 |
| 123 | response to parathyroid hormone (GO:0071107) | 3.38237625 |
| 124 | aromatic amino acid family catabolic process (GO:0009074) | 3.35248461 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 3.35005333 |
| 126 | tryptophan metabolic process (GO:0006568) | 3.34941315 |
| 127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.34931846 |
| 128 | ethanol oxidation (GO:0006069) | 3.33889017 |
| 129 | epithelial structure maintenance (GO:0010669) | 3.33505610 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.33052939 |
| 131 | lipid oxidation (GO:0034440) | 3.31375851 |
| 132 | adhesion of symbiont to host (GO:0044406) | 3.29537877 |
| 133 | cellular response to nitric oxide (GO:0071732) | 3.29133957 |
| 134 | cobalamin metabolic process (GO:0009235) | 3.28700402 |
| 135 | ATP synthesis coupled proton transport (GO:0015986) | 3.27537095 |
| 136 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.27537095 |
| 137 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.27354736 |
| 138 | L-phenylalanine metabolic process (GO:0006558) | 3.27354736 |
| 139 | intestinal epithelial cell development (GO:0060576) | 3.26844519 |
| 140 | polyol transport (GO:0015791) | 3.25578454 |
| 141 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.24481579 |
| 142 | acetyl-CoA metabolic process (GO:0006084) | 3.24453350 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23420719 |
| 144 | transcytosis (GO:0045056) | 3.20582970 |
| 145 | response to growth hormone (GO:0060416) | 3.18268133 |
| 146 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.18254554 |
| 147 | polyol catabolic process (GO:0046174) | 3.16917598 |
| 148 | heme transport (GO:0015886) | 3.16407732 |
| 149 | * regulation of cGMP biosynthetic process (GO:0030826) | 3.16162185 |
| 150 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.16162185 |
| 151 | leukotriene metabolic process (GO:0006691) | 3.15549898 |
| 152 | cellular modified amino acid catabolic process (GO:0042219) | 3.14726635 |
| 153 | glomerular filtration (GO:0003094) | 3.13815924 |
| 154 | fatty acid catabolic process (GO:0009062) | 3.12629075 |
| 155 | cellular amino acid catabolic process (GO:0009063) | 3.12095337 |
| 156 | metanephric nephron epithelium development (GO:0072243) | 3.12023831 |
| 157 | drug metabolic process (GO:0017144) | 3.10699106 |
| 158 | cytidine metabolic process (GO:0046087) | 3.09287837 |
| 159 | cytidine catabolic process (GO:0006216) | 3.09287837 |
| 160 | cytidine deamination (GO:0009972) | 3.09287837 |
| 161 | cellular response to reactive nitrogen species (GO:1902170) | 3.08800967 |
| 162 | response to phenylpropanoid (GO:0080184) | 3.07660885 |
| 163 | auditory receptor cell differentiation (GO:0042491) | 3.06999819 |
| 164 | interferon-gamma secretion (GO:0072643) | 3.05186057 |
| 165 | glycine metabolic process (GO:0006544) | 3.04319051 |
| 166 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.04310527 |
| 167 | lipoprotein metabolic process (GO:0042157) | 3.04196459 |
| 168 | sexual reproduction (GO:0019953) | 3.03513130 |
| 169 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.02594549 |
| 170 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02518905 |
| 171 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02518905 |
| 172 | response to nitric oxide (GO:0071731) | 3.02479372 |
| 173 | glycerol metabolic process (GO:0006071) | 3.01326190 |
| 174 | sphingomyelin metabolic process (GO:0006684) | 3.01185568 |
| 175 | sulfate transmembrane transport (GO:1902358) | 3.00013828 |
| 176 | glycosylceramide metabolic process (GO:0006677) | 2.97856596 |
| 177 | arginine metabolic process (GO:0006525) | 2.97503049 |
| 178 | O-glycan processing (GO:0016266) | 2.95853084 |
| 179 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.95784288 |
| 180 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.95784288 |
| 181 | sulfate transport (GO:0008272) | 2.94595105 |
| 182 | sphingolipid catabolic process (GO:0030149) | 2.93300269 |
| 183 | phospholipid efflux (GO:0033700) | 2.93060766 |
| 184 | fat-soluble vitamin metabolic process (GO:0006775) | 2.91145385 |
| 185 | vitamin A metabolic process (GO:0006776) | 2.91041520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.59571817 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.52376122 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50532121 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.46150466 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.44209837 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.31545448 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.04751140 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.98716667 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90894381 |
| 10 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.69723284 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.62027034 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.51569235 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.48963426 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47417357 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.45297797 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.38180123 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.34167440 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.34090632 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.33079799 |
| 20 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.15434201 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11859377 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.06971476 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06662479 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.06594985 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06026852 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.05252184 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02515475 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.01946055 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01577302 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.96871106 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93842638 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.93051216 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91432023 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.90687587 |
| 35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89918082 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89708813 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87770667 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85004745 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82499838 |
| 40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.81639632 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77405725 |
| 42 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.70416073 |
| 43 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.68583062 |
| 44 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.67424382 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64804499 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62950211 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61873444 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.60566348 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59912597 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58791358 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55073433 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54591623 |
| 53 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48905236 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48383634 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46947697 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.46797326 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46587052 |
| 58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44813760 |
| 59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44048188 |
| 60 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.43609814 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42957810 |
| 62 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.42811775 |
| 63 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.39058322 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.38853161 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38595293 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37713572 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35688398 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35506449 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35477521 |
| 70 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.34937023 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34875817 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34002769 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30656720 |
| 74 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.30502526 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29680211 |
| 76 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.28703632 |
| 77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28135975 |
| 78 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.27045392 |
| 79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26147952 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26035884 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26029398 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26018893 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25849768 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25059583 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23923231 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23242366 |
| 87 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.23221230 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23190637 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22637739 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21061009 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20102316 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19747083 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17451884 |
| 94 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.16170405 |
| 95 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15094445 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14611439 |
| 97 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14587319 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13591709 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12722491 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11967650 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11794075 |
| 102 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11762228 |
| 103 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11444535 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11356822 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09906155 |
| 106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08571710 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08420904 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08215407 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08056984 |
| 110 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.07415248 |
| 111 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06246527 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05135930 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05065525 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04927855 |
| 115 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04789800 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04518726 |
| 117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02099931 |
| 118 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02092658 |
| 119 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01989496 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01257068 |
| 121 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01081271 |
| 122 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.00833889 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99936262 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99341235 |
| 125 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.99248049 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97728007 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97538138 |
| 128 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97413381 |
| 129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97283080 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97212034 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95932348 |
| 132 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95875781 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95311696 |
| 134 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95130303 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95111146 |
| 136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94981827 |
| 137 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94833254 |
| 138 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94059126 |
| 139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93899767 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93887381 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93820839 |
| 142 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93604689 |
| 143 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93313550 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 0.93295465 |
| 145 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.93120324 |
| 146 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93095850 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92332449 |
| 148 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92049869 |
| 149 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90787747 |
| 150 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90738159 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90035508 |
| 152 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89888959 |
| 153 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89721472 |
| 154 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89333294 |
| 155 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87651927 |
| 156 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87292735 |
| 157 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.86876801 |
| 158 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.85638365 |
| 159 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85501839 |
| 160 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85325104 |
| 161 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85033892 |
| 162 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.84176865 |
| 163 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.83983209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.34611697 |
| 2 | MP0004043_abnormal_pH_regulation | 5.26397958 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 4.93504554 |
| 4 | MP0003878_abnormal_ear_physiology | 4.51892918 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 4.51892918 |
| 6 | MP0005332_abnormal_amino_acid | 4.27506611 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.68452894 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.61249200 |
| 9 | MP0009379_abnormal_foot_pigmentation | 3.59258652 |
| 10 | MP0009643_abnormal_urine_homeostasis | 3.58622485 |
| 11 | MP0003195_calcinosis | 3.13209024 |
| 12 | MP0001765_abnormal_ion_homeostasis | 3.12535429 |
| 13 | MP0001756_abnormal_urination | 3.05259389 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75131288 |
| 15 | MP0005636_abnormal_mineral_homeostasis | 2.60483355 |
| 16 | MP0002136_abnormal_kidney_physiology | 2.49566165 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.36111622 |
| 18 | MP0009840_abnormal_foam_cell | 2.32995939 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.28295557 |
| 20 | MP0001664_abnormal_digestion | 2.25849103 |
| 21 | MP0005409_darkened_coat_color | 2.20093723 |
| 22 | MP0005451_abnormal_body_composition | 2.11416052 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.10946027 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.09227199 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.06863453 |
| 26 | MP0001666_abnormal_nutrient_absorption | 2.06290127 |
| 27 | MP0005058_abnormal_lysosome_morphology | 2.03162183 |
| 28 | MP0005365_abnormal_bile_salt | 1.91856238 |
| 29 | MP0003868_abnormal_feces_composition | 1.75101369 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.65701322 |
| 31 | MP0004885_abnormal_endolymph | 1.65548790 |
| 32 | MP0005166_decreased_susceptibility_to | 1.59460783 |
| 33 | MP0001873_stomach_inflammation | 1.54624959 |
| 34 | MP0001958_emphysema | 1.54128264 |
| 35 | MP0003186_abnormal_redox_activity | 1.53725526 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.49840081 |
| 37 | MP0003718_maternal_effect | 1.48624882 |
| 38 | MP0003252_abnormal_bile_duct | 1.44616874 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.42725303 |
| 40 | MP0000538_abnormal_urinary_bladder | 1.39653998 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.37134750 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.34967249 |
| 43 | MP0001188_hyperpigmentation | 1.33030899 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.31220064 |
| 45 | MP0008260_abnormal_autophagy | 1.30745660 |
| 46 | MP0001764_abnormal_homeostasis | 1.30036504 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.28858081 |
| 48 | MP0004858_abnormal_nervous_system | 1.28492104 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24946402 |
| 50 | MP0003646_muscle_fatigue | 1.24124801 |
| 51 | MP0003724_increased_susceptibility_to | 1.19298126 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.19041959 |
| 53 | MP0003283_abnormal_digestive_organ | 1.17658360 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.16341554 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.14680651 |
| 56 | MP0002796_impaired_skin_barrier | 1.13541344 |
| 57 | MP0003303_peritoneal_inflammation | 1.12469423 |
| 58 | MP0003866_abnormal_defecation | 1.08231824 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.04875302 |
| 60 | MP0004147_increased_porphyrin_level | 1.02683842 |
| 61 | MP0001661_extended_life_span | 1.01852933 |
| 62 | MP0003879_abnormal_hair_cell | 0.99196477 |
| 63 | MP0005395_other_phenotype | 0.98626825 |
| 64 | MP0003436_decreased_susceptibility_to | 0.96746993 |
| 65 | MP0002971_abnormal_brown_adipose | 0.96254100 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.95386824 |
| 67 | MP0009785_altered_susceptibility_to | 0.95095218 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.94264796 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.93581250 |
| 70 | MP0000490_abnormal_crypts_of | 0.93557204 |
| 71 | MP0005448_abnormal_energy_balance | 0.93364163 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 0.92069510 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.90258681 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 0.89643083 |
| 75 | MP0003941_abnormal_skin_development | 0.87079842 |
| 76 | MP0004484_altered_response_of | 0.86856265 |
| 77 | MP0009115_abnormal_fat_cell | 0.85460765 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.83739534 |
| 79 | MP0005025_abnormal_response_to | 0.83500872 |
| 80 | MP0001730_embryonic_growth_arrest | 0.81608681 |
| 81 | MP0000537_abnormal_urethra_morphology | 0.80273916 |
| 82 | MP0000747_muscle_weakness | 0.80022730 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.78928351 |
| 84 | MP0002135_abnormal_kidney_morphology | 0.78483223 |
| 85 | MP0004270_analgesia | 0.76485055 |
| 86 | MP0000462_abnormal_digestive_system | 0.76323562 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.76204050 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.75321441 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.75188718 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.74470724 |
| 91 | MP0001835_abnormal_antigen_presentation | 0.74181071 |
| 92 | MP0008469_abnormal_protein_level | 0.73140230 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.73028075 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.73007508 |
| 95 | MP0004947_skin_inflammation | 0.71886188 |
| 96 | MP0000609_abnormal_liver_physiology | 0.71452957 |
| 97 | MP0006082_CNS_inflammation | 0.71027025 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.70786562 |
| 99 | MP0008004_abnormal_stomach_pH | 0.69262700 |
| 100 | MP0005501_abnormal_skin_physiology | 0.69105756 |
| 101 | MP0002822_catalepsy | 0.67958812 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.67778666 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.66322549 |
| 104 | MP0005670_abnormal_white_adipose | 0.65814037 |
| 105 | MP0000566_synostosis | 0.65488818 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.65049293 |
| 107 | MP0001849_ear_inflammation | 0.64779901 |
| 108 | MP0002168_other_aberrant_phenotype | 0.64693240 |
| 109 | MP0005387_immune_system_phenotype | 0.63722745 |
| 110 | MP0001790_abnormal_immune_system | 0.63722745 |
| 111 | MP0000249_abnormal_blood_vessel | 0.62738003 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.60637477 |
| 113 | MP0008872_abnormal_physiological_respon | 0.60450332 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.59774915 |
| 115 | MP0001663_abnormal_digestive_system | 0.59281931 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.59009585 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.57180192 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 0.56920837 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56845824 |
| 120 | MP0002098_abnormal_vibrissa_morphology | 0.56387509 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.55618377 |
| 122 | MP0005330_cardiomyopathy | 0.55507871 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.54752031 |
| 124 | MP0000604_amyloidosis | 0.52017361 |
| 125 | MP0005165_increased_susceptibility_to | 0.51874698 |
| 126 | MP0009764_decreased_sensitivity_to | 0.50662217 |
| 127 | MP0001800_abnormal_humoral_immune | 0.49966848 |
| 128 | MP0005310_abnormal_salivary_gland | 0.49333313 |
| 129 | MP0000598_abnormal_liver_morphology | 0.48824126 |
| 130 | MP0005535_abnormal_body_temperature | 0.48354178 |
| 131 | MP0003329_amyloid_beta_deposits | 0.47601467 |
| 132 | MP0009672_abnormal_birth_weight | 0.46207690 |
| 133 | MP0005266_abnormal_metabolism | 0.44831157 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.44371042 |
| 135 | MP0008932_abnormal_embryonic_tissue | 0.43677418 |
| 136 | MP0003938_abnormal_ear_development | 0.43663897 |
| 137 | MP0000358_abnormal_cell_content/ | 0.40810290 |
| 138 | MP0003984_embryonic_growth_retardation | 0.40458069 |
| 139 | MP0002269_muscular_atrophy | 0.40154798 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.39107731 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.38083121 |
| 142 | MP0001672_abnormal_embryogenesis/_devel | 0.37912427 |
| 143 | MP0005380_embryogenesis_phenotype | 0.37912427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 6.57348574 |
| 2 | Gout (HP:0001997) | 6.43961940 |
| 3 | Increased circulating renin level (HP:0000848) | 6.20882116 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.98329314 |
| 5 | Hypokalemic alkalosis (HP:0001949) | 5.80299452 |
| 6 | Hyperglycinuria (HP:0003108) | 5.79704551 |
| 7 | Hypomagnesemia (HP:0002917) | 5.62100467 |
| 8 | Proximal tubulopathy (HP:0000114) | 5.52430123 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 5.43797524 |
| 10 | Polyuria (HP:0000103) | 5.26810951 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.06234617 |
| 12 | Abnormal urine output (HP:0012590) | 5.05766109 |
| 13 | Abnormality of renal excretion (HP:0011036) | 4.81676370 |
| 14 | Hyperuricemia (HP:0002149) | 4.73324076 |
| 15 | Increased purine levels (HP:0004368) | 4.73324076 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.71677649 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.71677649 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.64166026 |
| 19 | Chronic diarrhea (HP:0002028) | 4.62913914 |
| 20 | Alkalosis (HP:0001948) | 4.12803508 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 4.12163628 |
| 22 | Abnormality of renin-angiotensin system (HP:0000847) | 4.12082284 |
| 23 | Hyperaldosteronism (HP:0000859) | 4.03030707 |
| 24 | Glycosuria (HP:0003076) | 4.00260870 |
| 25 | Abnormality of urine glucose concentration (HP:0011016) | 4.00260870 |
| 26 | Tetany (HP:0001281) | 3.93927729 |
| 27 | Renal salt wasting (HP:0000127) | 3.93140768 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.90734491 |
| 29 | Abnormal drinking behavior (HP:0030082) | 3.90268243 |
| 30 | Polydipsia (HP:0001959) | 3.90268243 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.78666095 |
| 32 | Hyperglycinemia (HP:0002154) | 3.70709261 |
| 33 | Fat malabsorption (HP:0002630) | 3.70707935 |
| 34 | Hypobetalipoproteinemia (HP:0003563) | 3.68773350 |
| 35 | Hemorrhage of the eye (HP:0011885) | 3.57511729 |
| 36 | Abdominal distention (HP:0003270) | 3.40800920 |
| 37 | Hypercalciuria (HP:0002150) | 3.32967262 |
| 38 | Hyperphosphaturia (HP:0003109) | 3.28399840 |
| 39 | Wide cranial sutures (HP:0010537) | 3.27736610 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 3.26424844 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22194043 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.21818748 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 3.14631602 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.14631602 |
| 45 | Hypokalemia (HP:0002900) | 3.11592599 |
| 46 | Acanthocytosis (HP:0001927) | 3.09105090 |
| 47 | Ileus (HP:0002595) | 3.07523928 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06704790 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 3.04405062 |
| 50 | Flat acetabular roof (HP:0003180) | 2.99884391 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.95252984 |
| 52 | Ketoacidosis (HP:0001993) | 2.92659248 |
| 53 | Abnormal urine phosphate concentration (HP:0012599) | 2.91992032 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.89662409 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.89662409 |
| 56 | Pigmentary retinal degeneration (HP:0001146) | 2.85180392 |
| 57 | Facial shape deformation (HP:0011334) | 2.83249924 |
| 58 | Potter facies (HP:0002009) | 2.83249924 |
| 59 | Lethargy (HP:0001254) | 2.79745906 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.73274733 |
| 61 | Renal tubular acidosis (HP:0001947) | 2.73171680 |
| 62 | Hyperammonemia (HP:0001987) | 2.72685387 |
| 63 | Nephrolithiasis (HP:0000787) | 2.71971152 |
| 64 | Malnutrition (HP:0004395) | 2.71786586 |
| 65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.65665995 |
| 66 | Villous atrophy (HP:0011473) | 2.65665995 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64202627 |
| 68 | Megaloblastic anemia (HP:0001889) | 2.55557983 |
| 69 | Ketosis (HP:0001946) | 2.54913569 |
| 70 | Methylmalonic aciduria (HP:0012120) | 2.53377891 |
| 71 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.50121483 |
| 72 | Enlarged epiphyses (HP:0010580) | 2.48934637 |
| 73 | Hypotension (HP:0002615) | 2.44387683 |
| 74 | Abnormality of potassium homeostasis (HP:0011042) | 2.43990070 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.43218288 |
| 76 | Dehydration (HP:0001944) | 2.43161948 |
| 77 | Nausea (HP:0002018) | 2.42627545 |
| 78 | Focal segmental glomerulosclerosis (HP:0000097) | 2.42362968 |
| 79 | Vomiting (HP:0002013) | 2.41068253 |
| 80 | Widely patent fontanelles and sutures (HP:0004492) | 2.38933863 |
| 81 | Posterior subcapsular cataract (HP:0007787) | 2.36646763 |
| 82 | Metabolic acidosis (HP:0001942) | 2.36445775 |
| 83 | Nephrocalcinosis (HP:0000121) | 2.31004374 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.30004990 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 2.29263374 |
| 86 | Abnormality of vitamin B metabolism (HP:0004340) | 2.29089779 |
| 87 | Steatorrhea (HP:0002570) | 2.28123353 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.25731749 |
| 89 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24040590 |
| 90 | Confusion (HP:0001289) | 2.23458033 |
| 91 | Hypophosphatemia (HP:0002148) | 2.20733232 |
| 92 | Vascular calcification (HP:0004934) | 2.18261018 |
| 93 | Hyponatremia (HP:0002902) | 2.16555594 |
| 94 | Pustule (HP:0200039) | 2.15011091 |
| 95 | Pili torti (HP:0003777) | 2.13699947 |
| 96 | Irritability (HP:0000737) | 2.13066742 |
| 97 | Protuberant abdomen (HP:0001538) | 2.12729950 |
| 98 | Rickets (HP:0002748) | 2.10925863 |
| 99 | Hyperphosphatemia (HP:0002905) | 2.09959566 |
| 100 | Abnormality of renal resorption (HP:0011038) | 2.09852124 |
| 101 | Delayed CNS myelination (HP:0002188) | 2.08141767 |
| 102 | Glomerulonephritis (HP:0000099) | 2.06950699 |
| 103 | Abnormality of sodium homeostasis (HP:0010931) | 2.06263650 |
| 104 | Acute encephalopathy (HP:0006846) | 2.03836493 |
| 105 | Growth hormone excess (HP:0000845) | 2.02751619 |
| 106 | Gingivitis (HP:0000230) | 2.02125977 |
| 107 | Metaphyseal cupping (HP:0003021) | 2.01938304 |
| 108 | Cerebral palsy (HP:0100021) | 2.01807843 |
| 109 | Subcapsular cataract (HP:0000523) | 2.01678866 |
| 110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98857327 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.96968556 |
| 112 | Hypolipoproteinemia (HP:0010981) | 1.94882286 |
| 113 | Petechiae (HP:0000967) | 1.94229146 |
| 114 | Abnormality of complement system (HP:0005339) | 1.93851259 |
| 115 | Pancreatitis (HP:0001733) | 1.91843839 |
| 116 | Abnormality of carpal bone ossification (HP:0006257) | 1.91187142 |
| 117 | Hepatic necrosis (HP:0002605) | 1.90503699 |
| 118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90151663 |
| 119 | Gastrointestinal dysmotility (HP:0002579) | 1.90146972 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.88218881 |
| 121 | Renal tubular dysfunction (HP:0000124) | 1.87135895 |
| 122 | Intrahepatic cholestasis (HP:0001406) | 1.85121547 |
| 123 | Xanthomatosis (HP:0000991) | 1.83524087 |
| 124 | Nephritis (HP:0000123) | 1.82743157 |
| 125 | Abnormality of the costochondral junction (HP:0000919) | 1.81866946 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.81734650 |
| 127 | Abnormal hair laboratory examination (HP:0003328) | 1.80042772 |
| 128 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79997070 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79938321 |
| 130 | Abnormal albumin level (HP:0012116) | 1.79494329 |
| 131 | Hypoalbuminemia (HP:0003073) | 1.79494329 |
| 132 | Hypoglycemic coma (HP:0001325) | 1.78473251 |
| 133 | Multiple lipomas (HP:0001012) | 1.77955869 |
| 134 | Complement deficiency (HP:0004431) | 1.77898107 |
| 135 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77047569 |
| 136 | Carpal bone hypoplasia (HP:0001498) | 1.76414101 |
| 137 | Bicornuate uterus (HP:0000813) | 1.75336123 |
| 138 | Decreased circulating renin level (HP:0003351) | 1.72762883 |
| 139 | Cerebral edema (HP:0002181) | 1.72127716 |
| 140 | Thin bony cortex (HP:0002753) | 1.71493602 |
| 141 | Bone pain (HP:0002653) | 1.71176493 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 1.70555355 |
| 143 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.68092502 |
| 144 | Chondrocalcinosis (HP:0000934) | 1.67677659 |
| 145 | Abnormal pancreas size (HP:0012094) | 1.67045244 |
| 146 | Adrenal overactivity (HP:0002717) | 1.66252431 |
| 147 | Spastic paraparesis (HP:0002313) | 1.65115874 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.63107535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 6.53866765 |
| 2 | WNK4 | 6.41779699 |
| 3 | WNK3 | 5.94425082 |
| 4 | OXSR1 | 5.27698088 |
| 5 | ERN1 | 4.55604831 |
| 6 | EPHA2 | 3.64998063 |
| 7 | NEK1 | 3.24980137 |
| 8 | BUB1 | 3.13251964 |
| 9 | WEE1 | 2.88929834 |
| 10 | STK39 | 2.87257666 |
| 11 | PDK3 | 2.79459642 |
| 12 | PDK4 | 2.79459642 |
| 13 | BCKDK | 2.48393147 |
| 14 | STK38L | 2.32865899 |
| 15 | MAP3K10 | 2.26694982 |
| 16 | PNCK | 2.25304799 |
| 17 | PDK2 | 2.16812988 |
| 18 | EPHB2 | 1.82120009 |
| 19 | RIPK4 | 1.75338907 |
| 20 | MST1R | 1.72567796 |
| 21 | MST4 | 1.71693987 |
| 22 | MAP4K1 | 1.63541108 |
| 23 | TYK2 | 1.60332118 |
| 24 | NME2 | 1.57135444 |
| 25 | TTK | 1.56004878 |
| 26 | NME1 | 1.52395043 |
| 27 | GRK6 | 1.50044701 |
| 28 | MAP2K2 | 1.49051876 |
| 29 | PRKCI | 1.40499760 |
| 30 | MAP3K2 | 1.36014465 |
| 31 | STK16 | 1.35042693 |
| 32 | PRPF4B | 1.32231901 |
| 33 | TSSK6 | 1.30748181 |
| 34 | EPHA3 | 1.23354833 |
| 35 | EIF2AK1 | 1.21238240 |
| 36 | MAP3K1 | 1.15979430 |
| 37 | SGK223 | 1.15795683 |
| 38 | SGK494 | 1.15795683 |
| 39 | PAK4 | 1.15284021 |
| 40 | STK24 | 1.07576006 |
| 41 | AKT3 | 1.06036956 |
| 42 | TRIB3 | 1.06019652 |
| 43 | MAP3K12 | 1.03198951 |
| 44 | LMTK2 | 0.98182295 |
| 45 | CDC42BPA | 0.94888561 |
| 46 | PLK4 | 0.94483908 |
| 47 | DYRK1B | 0.91937642 |
| 48 | STK38 | 0.89930459 |
| 49 | WNK1 | 0.89082700 |
| 50 | EPHA4 | 0.87889989 |
| 51 | IRAK3 | 0.87167691 |
| 52 | ERBB2 | 0.86928155 |
| 53 | MAP3K3 | 0.83387287 |
| 54 | NEK2 | 0.82834333 |
| 55 | FGFR3 | 0.80626371 |
| 56 | FRK | 0.79862649 |
| 57 | MAP3K11 | 0.78806016 |
| 58 | TBK1 | 0.77772930 |
| 59 | PIK3CA | 0.77707384 |
| 60 | BRAF | 0.74773049 |
| 61 | KSR2 | 0.74715464 |
| 62 | CSK | 0.72367114 |
| 63 | TESK2 | 0.70882511 |
| 64 | TNIK | 0.70783594 |
| 65 | FGFR4 | 0.70366654 |
| 66 | EPHB1 | 0.67609551 |
| 67 | PRKG2 | 0.65913541 |
| 68 | MAP3K8 | 0.62920740 |
| 69 | AURKA | 0.61669875 |
| 70 | BRSK2 | 0.61124398 |
| 71 | PINK1 | 0.60171741 |
| 72 | PLK1 | 0.60069277 |
| 73 | ZAP70 | 0.59701064 |
| 74 | AURKB | 0.59683214 |
| 75 | DDR2 | 0.59118777 |
| 76 | ARAF | 0.59056041 |
| 77 | NLK | 0.58541538 |
| 78 | MYLK | 0.58484688 |
| 79 | IRAK4 | 0.57097057 |
| 80 | SGK3 | 0.56587036 |
| 81 | GSK3A | 0.56529587 |
| 82 | PDPK1 | 0.55741445 |
| 83 | SIK1 | 0.54143393 |
| 84 | NEK9 | 0.53623090 |
| 85 | PRKAA1 | 0.53466886 |
| 86 | LRRK2 | 0.52190058 |
| 87 | BLK | 0.51612886 |
| 88 | IRAK1 | 0.49783518 |
| 89 | EIF2AK3 | 0.48535306 |
| 90 | RET | 0.47233575 |
| 91 | SMG1 | 0.47092852 |
| 92 | FER | 0.46860043 |
| 93 | IKBKE | 0.46450871 |
| 94 | AKT2 | 0.46104004 |
| 95 | BMX | 0.46100098 |
| 96 | MAPK15 | 0.46058324 |
| 97 | PAK1 | 0.45857640 |
| 98 | SRC | 0.44834252 |
| 99 | JAK2 | 0.43462011 |
| 100 | ABL2 | 0.43376845 |
| 101 | DAPK2 | 0.42886168 |
| 102 | MAP3K14 | 0.42782253 |
| 103 | TAOK1 | 0.42278818 |
| 104 | MET | 0.41323850 |
| 105 | JAK1 | 0.40974006 |
| 106 | FYN | 0.40760380 |
| 107 | PTK2 | 0.39431553 |
| 108 | YES1 | 0.39312792 |
| 109 | SGK2 | 0.38997092 |
| 110 | MATK | 0.38671233 |
| 111 | PIM1 | 0.36712364 |
| 112 | CDK19 | 0.36373999 |
| 113 | CSF1R | 0.36364364 |
| 114 | PDGFRA | 0.35985302 |
| 115 | RPS6KA2 | 0.35964858 |
| 116 | PIM2 | 0.35734970 |
| 117 | ZAK | 0.35062000 |
| 118 | STK10 | 0.33123300 |
| 119 | DYRK3 | 0.32709158 |
| 120 | LYN | 0.31848390 |
| 121 | PRKCD | 0.31386778 |
| 122 | MAP2K6 | 0.30703131 |
| 123 | TESK1 | 0.30127989 |
| 124 | PAK3 | 0.29266759 |
| 125 | JAK3 | 0.28960376 |
| 126 | BTK | 0.28740286 |
| 127 | CHEK2 | 0.27339353 |
| 128 | ITK | 0.27322795 |
| 129 | MAPKAPK2 | 0.27160929 |
| 130 | TIE1 | 0.26938123 |
| 131 | CSNK1E | 0.26836972 |
| 132 | PRKCQ | 0.26142758 |
| 133 | SYK | 0.26135247 |
| 134 | PRKD2 | 0.26016354 |
| 135 | KDR | 0.22551075 |
| 136 | CDK6 | 0.21341010 |
| 137 | MAP2K1 | 0.21285911 |
| 138 | MAP3K7 | 0.20952280 |
| 139 | PRKCZ | 0.20837464 |
| 140 | CAMK2G | 0.20809179 |
| 141 | PLK3 | 0.20572321 |
| 142 | RPS6KC1 | 0.20000797 |
| 143 | SGK1 | 0.19846994 |
| 144 | CAMK2D | 0.19512615 |
| 145 | PDK1 | 0.19343634 |
| 146 | STK11 | 0.18461139 |
| 147 | PRKCG | 0.17754707 |
| 148 | PRKAA2 | 0.17392583 |
| 149 | MAPK11 | 0.17338221 |
| 150 | PRKCA | 0.17162541 |
| 151 | CSNK1A1 | 0.16901022 |
| 152 | RIPK1 | 0.16400624 |
| 153 | MTOR | 0.15648139 |
| 154 | PTK6 | 0.15134729 |
| 155 | CDK4 | 0.14552425 |
| 156 | PRKACG | 0.13897511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.54916844 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.21429160 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.21380646 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.03662555 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90118690 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.84686976 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.81545630 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.72088417 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55050556 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.52713291 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52001790 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.48501496 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.43979956 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13645207 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.11706978 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.08348822 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.99130696 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.97771053 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93616084 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.89644515 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87387366 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.84614901 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82627787 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75890958 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74375765 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66069042 |
| 27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.55633774 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52131030 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51332162 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51268191 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.42811666 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.39359998 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38983709 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37848364 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36658332 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29776740 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.27298870 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24200696 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22402091 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18519196 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18510677 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17215536 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16851215 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14493717 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13208613 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13055569 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12911206 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10241876 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09010529 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06698516 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.06502525 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06026186 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05963025 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04892530 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03424294 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02757966 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02218619 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96564423 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91968400 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91005093 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89713922 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.86247399 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80946939 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80148707 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79878602 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78481595 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76560851 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74919053 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72841374 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72135981 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69449883 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68401481 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66892709 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65873030 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63950267 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63206313 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62045861 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58907118 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58845962 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58478707 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58026275 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57489820 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55642025 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54942676 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54394018 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53771787 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.53546814 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53034575 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.50263894 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48828009 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48762672 |
| 92 | RNA polymerase_Homo sapiens_hsa03020 | 0.45751317 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.44564190 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44369112 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.44238146 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44066353 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41904800 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41568878 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41351833 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.40998849 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.40772541 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39017200 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37110275 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.36560410 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.36294194 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33158417 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32713261 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29923534 |
| 109 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28995920 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27955280 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26626319 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.24625826 |
| 113 | Ribosome_Homo sapiens_hsa03010 | 0.19319982 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19307452 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.17698061 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.17499362 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17247627 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17032473 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16962617 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14849794 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14825103 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14824490 |
| 123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.14803193 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.13968691 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.13628658 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13335707 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13125282 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.12171143 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12068052 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11706158 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.11446880 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.10749623 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.10238788 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07723838 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.07523593 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.07340202 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.06845969 |

